Koselugo

Medicinal product

(Invented) name

Koselugo

Active substance (s)

Selumetinibas

Strength

7,5 mg

Pharmaceutical form

granulės atidaromose kapsulėse

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EE04, selumetinib

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2021-06-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Selumetinibas	7,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119626	105732	1105732	buteliukas	N60		Receptinis	EU/1/21/1552/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-17	Registruotas